PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The PiSZ genotype results in less severe deficiency of alpha-1 antitrypsin (AAT) than PiZZ. Less is known about phenotypic and prognostic features.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Thorax

Title: Thorax

Publisher: BMJ

ISSN (Electronic): 1468-3296

ISSN (Print): 0040-6376

Publication date (Electronic): Oct 2015

Volume: 70

Issue: 10

Affiliations

[1 ] Centre for Translational Inflammation Research, University of Birmingham, Birmingham, UK.

[2 ] Imperial College, London, UK.

[3 ] Centre for Translational Inflammation Research, University of Birmingham, Birmingham, UK Heart of England NHS Foundation Trust, Birmingham, UK.

Article

Publisher Item ID: thoraxjnl-2015-206906

DOI: 10.1136/thoraxjnl-2015-206906

PubMed ID: 26141072

SO-VID: eac51919-b6ad-4e58-bf6e-c8ca60780688

History

Keywords: COPD epidemiology,Alpha1 Antitrypsin Deficiency,Tobacco and the lung,Emphysema

Data availability:

Keywords: COPD epidemiology, Alpha1 Antitrypsin Deficiency, Tobacco and the lung, Emphysema

PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.

Read this article at

Abstract

Related collections

UCL: UN SDG 01 No Poverty

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 25